ZURICH A scientist investigating rare blood clots possibly linked to AstraZeneca's and Johnson & Johnson's COVID-19 vaccines has yet to start a planned collaboration with the U.S. company, he said, as talks over their research pact continue.
WALD/DAVOS, Switzerland (Reuters) -Swiss mountain sanatoriums whose fresh-air and sunlight cures once drew tuberculosis patients from across Europe are reinventing themselves for a new generation: Patients suffering from the lingering effects of COVID-19.
* Approach contrasts with U.S., UK long COVID outpatient
BRUSSELS The European Union has secured about 55,000 doses of a potential treatment for COVID-19 based on a cocktail of monoclonal antibodies developed by U.S. drugmaker Regeneron and Swiss pharmaceutical giant Roche, an EU spokesman said.
ZURICH Men with a deadly form of advanced prostate cancer who failed other treatments survived four months longer after getting an experimental, tumour-targeting radiation therapy from Swiss drugmaker Novartis, data released on Thursday showed.
GENEVA/ZURICH (Reuters) -Countries and private donors pledged nearly $2.4 billion on Wednesday to the COVAX vaccine-sharing plan, expanding efforts to make COVID-19 shots more available to people in poorer nations.
ZURICH (Reuters) -Moderna is gearing up to halve the dose of its COVID-19 vaccine, the U.S. drugmaker said on Wednesday, so that it can also be used to combat variants and inoculate children.
ZURICH (Reuters) -International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they investigate reports of extremely rare, but potentially fatal blood clots.